Skip to main content
Erschienen in: European Radiology 6/2017

19.10.2016 | Gastrointestinal

Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours

verfasst von: Jin Sil Kim, Hyun Jin Kim, Seong Ho Park, Jong Seok Lee, Ah Young Kim, Hyun Kwon Ha

Erschienen in: European Radiology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the CT features of ruptured GISTs and factors that might be predictive of rupture through comparison with CTs taken prior to rupture and CTs of non-ruptured GIST.

Methods

Forty-nine patients with ruptured GIST and forty-nine patients with non-ruptured GIST matched by age, gender and location were included. Clinical data including pharmacotherapy were reviewed. The imaging features were analyzed. Prior CT obtained before rupture were evaluated.

Results

The most common location of ruptured GIST was small bowel with mean size of 12.1 cm. Ruptured GIST commonly showed wall defects, >40 % eccentric necrosis, lobulated shaped, air density in mass, pneumoperitoneum, peritonitis, hemoperitoneum and ascites (p < 0.001–0.030). Twenty-seven of 30 patients with follow up imaging received targeted therapy. During follow-up, thickness of the tumour wall decreased. Increase in size and progression of necrosis were common during targeted therapy (p = 0.017).
Newly developed ascites, peritonitis and hemoperitoneum was more common (p < 0.001–0.036).

Conclusion

Ruptured GISTs commonly demonstrate large size, >40 % eccentric necrosis, wall defects and lobulated shape. The progression of necrosis with increase in size and decreased wall thickness during targeted therapy may increase the risk of rupture. Rupture should be considered when newly developed peritonitis, hemoperitoneum, or ascites are noted during the follow-up.

Key points

Ruptured GISTs demonstrate large size, eccentric necrosis, wall defects, and lobulated shape.
Rupture should be considered when peritonitis or hemoperitoneum/adjacent hematoma newly appears.
Progression of necrosis with increase in size increases the risk of rupture.
Literatur
1.
Zurück zum Zitat Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580CrossRefPubMed Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580CrossRefPubMed
2.
Zurück zum Zitat Yang J, Yu J, Ma Z, Kang W, Tian S, Ye X (2015) Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases. Zhonghua Wai Ke Za Zhi 53:274–279PubMed Yang J, Yu J, Ma Z, Kang W, Tian S, Ye X (2015) Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases. Zhonghua Wai Ke Za Zhi 53:274–279PubMed
3.
Zurück zum Zitat Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480CrossRefPubMed Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480CrossRefPubMed
4.
Zurück zum Zitat Hohenberger P, Ronellenfitsch U, Oladeji O et al (2010) Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 97:1854–1859CrossRefPubMed Hohenberger P, Ronellenfitsch U, Oladeji O et al (2010) Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 97:1854–1859CrossRefPubMed
5.
Zurück zum Zitat Baheti AD, Shinagare AB, O'Neill AC et al (2015) MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol 88:20150085CrossRefPubMedPubMedCentral Baheti AD, Shinagare AB, O'Neill AC et al (2015) MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience. Br J Radiol 88:20150085CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Chok AY, Goh BK, Koh YX et al (2015) Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients. Ann Surg Oncol 22:3597–3605CrossRefPubMed Chok AY, Goh BK, Koh YX et al (2015) Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients. Ann Surg Oncol 22:3597–3605CrossRefPubMed
7.
Zurück zum Zitat Cegarra-Navarro MF, de la Calle MA, Girela-Baena E, Garcia-Santos JM, Lloret-Estan F, de Andres EP (2005) Ruptured gastrointestinal stromal tumors: radiologic findings in six cases. Abdom Imaging 30:535–542CrossRefPubMed Cegarra-Navarro MF, de la Calle MA, Girela-Baena E, Garcia-Santos JM, Lloret-Estan F, de Andres EP (2005) Ruptured gastrointestinal stromal tumors: radiologic findings in six cases. Abdom Imaging 30:535–542CrossRefPubMed
8.
Zurück zum Zitat Pinaikul S, Woodtichartpreecha P, Kanngurn S, Leelakiatpaiboon S (2014) 1189 Gastrointestinal stromal tumor (GIST): computed tomographic features and correlation of CT findings with histologic grade. J Med Assoc Thai 97:1189–1198PubMed Pinaikul S, Woodtichartpreecha P, Kanngurn S, Leelakiatpaiboon S (2014) 1189 Gastrointestinal stromal tumor (GIST): computed tomographic features and correlation of CT findings with histologic grade. J Med Assoc Thai 97:1189–1198PubMed
9.
Zurück zum Zitat Arolfo S, Teggia PM, Nano M (2011) Gastrointestinal stromal tumors: thirty years experience of an institution. World J Gastroenterol 17:1836–1839CrossRefPubMedPubMedCentral Arolfo S, Teggia PM, Nano M (2011) Gastrointestinal stromal tumors: thirty years experience of an institution. World J Gastroenterol 17:1836–1839CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S (2002) Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33:669–676CrossRefPubMed Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S (2002) Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33:669–676CrossRefPubMed
11.
Zurück zum Zitat Zhou C, Duan X, Zhang X, Hu H, Wang D, Shen J (2015) Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour. Eur Radiol 1–8 Zhou C, Duan X, Zhang X, Hu H, Wang D, Shen J (2015) Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour. Eur Radiol 1–8
12.
Zurück zum Zitat Tirumani SH, Shinagare AB, O’Neill AC, Nishino M, Rosenthal MH, Ramaiya NH (2016) Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients. Eur Radiol 26:286–295CrossRefPubMed Tirumani SH, Shinagare AB, O’Neill AC, Nishino M, Rosenthal MH, Ramaiya NH (2016) Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients. Eur Radiol 26:286–295CrossRefPubMed
13.
Zurück zum Zitat Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist's guide to treatment response criteria in oncologic imaging: Functional, molecular, and disease-specific imaging biomarkers. Am J Roentgenol 201:246–256CrossRef Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist's guide to treatment response criteria in oncologic imaging: Functional, molecular, and disease-specific imaging biomarkers. Am J Roentgenol 201:246–256CrossRef
14.
Zurück zum Zitat Yang TH, Hwang JI, Yang MS et al (2007) Gastrointestinal stromal tumors: computed tomographic features and prediction of malignant risk from computed tomographic imaging. J Chin Med Assoc 70:367–373CrossRefPubMed Yang TH, Hwang JI, Yang MS et al (2007) Gastrointestinal stromal tumors: computed tomographic features and prediction of malignant risk from computed tomographic imaging. J Chin Med Assoc 70:367–373CrossRefPubMed
15.
Zurück zum Zitat Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414CrossRefPubMed Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414CrossRefPubMed
16.
Zurück zum Zitat Lee NK, Kim S, Kim GH et al (2010) Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. Radiographics 30:1915–1934CrossRefPubMed Lee NK, Kim S, Kim GH et al (2010) Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. Radiographics 30:1915–1934CrossRefPubMed
17.
Zurück zum Zitat Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 33:466–477CrossRefPubMed Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 33:466–477CrossRefPubMed
18.
Zurück zum Zitat Komatsu Y, Ohki E, Ueno N et al (2015) Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor. Jpn J Clin Oncol. doi:10.1093/jjco/hyv126 PubMedCentral Komatsu Y, Ohki E, Ueno N et al (2015) Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor. Jpn J Clin Oncol. doi:10.​1093/​jjco/​hyv126 PubMedCentral
19.
Zurück zum Zitat Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T (2005) Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer 103:1800–1809CrossRefPubMed Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T (2005) Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer 103:1800–1809CrossRefPubMed
20.
Zurück zum Zitat El-Kenawi AE, El-Remessy AB (2013) Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol 170:712–729CrossRefPubMedPubMedCentral El-Kenawi AE, El-Remessy AB (2013) Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br J Pharmacol 170:712–729CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kim KW, Shinagare AB, Krajewski KM et al (2015) Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol 16:304–313CrossRefPubMedPubMedCentral Kim KW, Shinagare AB, Krajewski KM et al (2015) Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management. Korean J Radiol 16:304–313CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Misawa S, Takeda M, Sakamoto H, Kirii Y, Ota H, Takagi H (2014) Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review. World J Surg Oncol 12:153CrossRefPubMedPubMedCentral Misawa S, Takeda M, Sakamoto H, Kirii Y, Ota H, Takagi H (2014) Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review. World J Surg Oncol 12:153CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographics 12:1051–1068CrossRefPubMed Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR (1992) Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with CT. Radiographics 12:1051–1068CrossRefPubMed
25.
Zurück zum Zitat (2014) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 Suppl 3:iii21–26 (2014) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 Suppl 3:iii21–26
Metadaten
Titel
Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours
verfasst von
Jin Sil Kim
Hyun Jin Kim
Seong Ho Park
Jong Seok Lee
Ah Young Kim
Hyun Kwon Ha
Publikationsdatum
19.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 6/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4515-z

Weitere Artikel der Ausgabe 6/2017

European Radiology 6/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.